As the number of tumor-infiltrating lymphoid and myeloid cells were not significantly altered in CaMKK2 KO GBM-bearing mice, we investigated the contribution of CaMMK2 to tumor-infiltrating immune cell phenotypes. The gene discussed is CAMKK2; the disease is glioblastoma.